| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 04/15/2004 | CA2500727A1 Vasculostatic agents and methods of use thereof |
| 04/14/2004 | EP1408037A1 Novel diarylmethylpiperazine and diarylmethylphenyl compounds with analgesic effect |
| 04/14/2004 | EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 04/14/2004 | EP1406877A1 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406620A1 Vinyl phenyl derivatives as glk activators |
| 04/14/2004 | CN1489458A Inhibitors against the production and releaseof inflammator cytokines |
| 04/14/2004 | CN1145615C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 04/08/2004 | WO2004000318A3 Certain amino-substituted monocycles as kinase modulators |
| 04/08/2004 | US20040068115 Charge transport compositions and electronic devices made with such compositions |
| 04/08/2004 | US20040068113 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 04/08/2004 | US20040067952 Method and composition for treatment of cancer |
| 04/08/2004 | US20040066135 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/06/2004 | CA2105937C Pyrazine preparation |
| 04/01/2004 | WO2004026305A1 Diaryl ethers as opioid receptor antagonist |
| 04/01/2004 | WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/01/2004 | WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003082874A3 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 04/01/2004 | US20040063693 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
| 03/31/2004 | EP1403250A1 Bis(5-aryl-2-pyridyl) derivative |
| 03/31/2004 | EP1401820A1 5-ht receptor ligands and uses thereof |
| 03/31/2004 | EP1401819A1 5-ht receptor ligands and uses thereof |
| 03/31/2004 | EP1401575A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 03/31/2004 | EP1299401B1 Chiral ligands for asymmetric catalysis |
| 03/31/2004 | EP1021439B1 Crystalline antifungal polymorph |
| 03/30/2004 | US6713472 Thiazine or pyrazine derivatives |
| 03/30/2004 | CA2314115C Process for the optical resolution of the racemic 6-(4-amino-phenyl)-5- methyl-pyridazin-3(2h)one |
| 03/25/2004 | WO2004024878A2 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/25/2004 | WO2004024719A1 Substituted 1,4-pyrazine derivatives |
| 03/25/2004 | WO2004000820A3 Certain aromatic monocycles as kinase modulators |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003041728A8 Novel phenyl-propargylether derivatives |
| 03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
| 03/25/2004 | US20040058933 Aryl carbamate derivatives, preperation and use thereof |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058903 Anticholesterol agents; cardiovascular disorders |
| 03/25/2004 | US20040058091 Anisotropic films based on 1,8-naphthoylene-1',2'-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |
| 03/25/2004 | CA2498936A1 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/25/2004 | CA2494975A1 Substituted 1,4-pyrazine derivatives |
| 03/24/2004 | EP1400518A1 Heterocyclic compound derivatives and medicines |
| 03/24/2004 | EP1399428A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/24/2004 | CN1142910C Amide compounds |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/23/2004 | US6711394 RF receiver having cascaded filters and an intermediate amplifier stage |
| 03/23/2004 | US6710906 Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices |
| 03/23/2004 | US6710186 Conformationally-restricted; analogous to poly(proline) ii helical structure |
| 03/23/2004 | US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders |
| 03/23/2004 | US6710055 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbo quinoline-8-sulfonylamino)-indole |
| 03/23/2004 | US6710048 Selective inhibitors of vascular endothelial growth factor receptor tyrosine kinase; to treat solid-tumor cancers, angiogenesis, diabetic retinopathy, rheumatoid arthritis, endometriosis and psoriasis |
| 03/23/2004 | US6710043 Possess the potentiation of the cholinergic activity |
| 03/18/2004 | WO2004022548A1 Process for producing oxycarbonyl-substituted piperazine derivative |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004006355A3 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 03/18/2004 | WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain |
| 03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 03/18/2004 | US20040053927 Certain amino-substituted monocycles as kinase modulators |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
| 03/17/2004 | EP1397505A2 Characterising polypeptides |
| 03/17/2004 | EP1397360A1 Azaindoles |
| 03/17/2004 | EP1397351A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/16/2004 | US6706740 Controlling, prevention fungi infections |
| 03/16/2004 | US6706729 A method for dissociating a metal ion from a zinc finger-containing protein; inhibiting virus |
| 03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
| 03/11/2004 | WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | US20040049030 Such as naphthalenes, anthracenes, phenanthrenes, tetracenes, perylenes, terrylenes, quaterrylenes, pentarylenes, hexarylenes, anthraquinones, indanthrones, and N-substituted naphthalene-1,8-dicarboxylic monoimides |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048895 Caspase-1 inhibitors and methods for their use |
| 03/11/2004 | US20040048891 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 03/11/2004 | US20040048864 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/11/2004 | US20040048862 Chemical compounds |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | CN1481382A Isoindolin-1-one glucokinase activators |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/10/2004 | CN1141299C Process for preparing 5-methylpyrazine-2-carboxylic acid from KMnO4 by one-step oxidizing method |
| 03/04/2004 | WO2004018437A1 5-substituted-2-arylpyrazines as modulators of crf receptors |
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 03/04/2004 | WO2004018428A1 Antibacterial benzoic acid derivatives |
| 03/04/2004 | WO2003043735A3 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions |
| 03/04/2004 | WO2003040402A3 Alpha-helix mimicry by a class of organic molecules |
| 03/04/2004 | US20040044251 Optical communication |
| 03/04/2004 | US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders |
| 03/04/2004 | US20040043979 Antiarthritic agents; cardiovascular disorders; imflammatory bowel disorders; skin disordfers; vision disorders |
| 03/04/2004 | CA2496197A1 5-substituted-2-arylpyrazines as modulators of crf receptors |
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1392308A1 Alpha-2-adrenergic agonist/fatty acid compositions |